Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Judson

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Pharmacokinetic modelling--a prelude to therapeutic drug monitoring for all cancer patients?I R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Understanding anticancer drug resistance: opportunities for modulation and impact on new drug designI R Judson
British Medical Journal (Clinical Research Ed.)|August 24, 1985
Relation between recurrence of cancer of the colon and blood transfusionD Francis, R Judson
Pharmacogenomics|March 22, 2001
Notes from the SNP vs. haplotype frontR Judson, J C Stephens
Veterinary Microbiology|April 1, 1991
Corynebacterium pseudotuberculosis: in vitro susceptibility to 39 antimicrobial agentsR Judson, J G Songer
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimenI R Judson, E Wiltshaw
Lancet (London, England)|September 3, 1983
A near-death experienceI R Judson, E Wiltshaw
Expert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R Judson
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of hexamethylmelamine in miceI R Judson, C J Rutty
Lancet (London, England)|September 11, 1993
Poly(ADP-ribosylation) as target for cancer chemotherapyI R Judson, M D Threadgill
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Pharmacokinetic modelling--a prelude to therapeutic drug monitoring for all cancer patients?I R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Understanding anticancer drug resistance: opportunities for modulation and impact on new drug designI R Judson
British Medical Journal (Clinical Research Ed.)|August 24, 1985
Relation between recurrence of cancer of the colon and blood transfusionD Francis, R Judson
Pharmacogenomics|March 22, 2001
Notes from the SNP vs. haplotype frontR Judson, J C Stephens
Veterinary Microbiology|April 1, 1991
Corynebacterium pseudotuberculosis: in vitro susceptibility to 39 antimicrobial agentsR Judson, J G Songer
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimenI R Judson, E Wiltshaw
Lancet (London, England)|September 3, 1983
A near-death experienceI R Judson, E Wiltshaw
Expert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R Judson
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of hexamethylmelamine in miceI R Judson, C J Rutty
Lancet (London, England)|September 11, 1993
Poly(ADP-ribosylation) as target for cancer chemotherapyI R Judson, M D Threadgill
Pageof 14